Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DRTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 44.06M
March 31, 2026 69.35M
December 31, 2025 77.10M
September 30, 2025 77.58M
June 30, 2025 86.62M
March 31, 2025 56.32M
December 31, 2024 62.67M
September 30, 2024 69.40M
June 30, 2024 74.02M
March 31, 2024 79.07M
December 31, 2023 84.48M
September 30, 2023 89.85M
Date Value
June 30, 2023 92.56M
March 31, 2023 99.18M
December 31, 2022 105.66M
September 30, 2022 107.26M
June 30, 2022 108.27M
March 31, 2022 93.99M
December 31, 2021 -34.78M
September 30, 2021 250.83M
June 30, 2021 250.58M
March 31, 2021 253.05M
December 31, 2020 -8.429M
September 30, 2020 0.0241M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Odysight.ai, Inc. 17.39M
Co-Diagnostics, Inc. 12.71M
Ondine Biomedical, Inc. --
Fractyl Health, Inc. -1.665M
Polyrizon Ltd. --

Shareholders Equity (Quarterly) Related Metrics